EGFR and type 2 diabetes mellitus: The miR-135a-3p cargo of exosomes in type II Diabetes mellitus patients has also been proposed to mediate vascular pathologies by activating the ERBB signaling vascular smooth muscle cells, resulting in their promoting abnormal proliferation and migration exacerbating vascular damage [162].